Related Experiment Video
Updated: Jan 6, 2026
Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
Published on: May 29, 2021
In Silico Insights towards the Identification of NLRP3 Druggable Hot Spots
Nedra Mekni1, Maria De Rosa2, Chiara Cipollina3,4
1Drug Discovery Unit, Fondazione Ri.MED, 90133 Palermo, Italy. nmekni@fondazionerimed.com.
Abstract:
NLRP3 (NOD-like receptor family, pyrin domain-containing protein 3) activation has been linked to several chronic pathologies, including atherosclerosis, type-II diabetes, fibrosis, rheumatoid arthritis, and Alzheimer's disease. Therefore, NLRP3 represents an appealing target for the development of innovative therapeutic approaches. A few companies are currently working on the discovery of selective modulators of NLRP3 inflammasome. Unfortunately, limited structural data are available for this target. To date, MCC950 represents one of the most promising noncovalent NLRP3 inhibitors. Recently, a possible region for the binding of MCC950 to the NLRP3 protein was described but no details were disclosed regarding the key interactions. In this communication, we present an in silico multiple approach as an insight useful for the design of novel NLRP3 inhibitors. In detail, combining different computational techniques, we propose consensus-retrieved protein residues that seem to be essential for the binding process and for the stabilization of the protein-ligand complex.
Insights
NLRP3 inflammasome inhibitors are crucial for treating chronic diseases. This study uses computational methods to identify key protein residues essential for NLRP3 inhibitor binding and stabilization.
Area of Science:
- Biochemistry
- Computational Biology
- Drug Discovery
Background:
- NLRP3 inflammasome activation is implicated in chronic diseases like atherosclerosis, diabetes, and Alzheimer's.
- Targeting NLRP3 is a promising therapeutic strategy, but limited structural data hinders inhibitor design.
- MCC950 is a notable noncovalent NLRP3 inhibitor, yet its precise binding interactions remain unclear.
Purpose of the Study:
- To computationally identify critical protein residues for NLRP3 inhibitor binding.
- To provide insights for designing novel and effective NLRP3 inhibitors.
Main Methods:
- Utilized a multi-in silico approach combining various computational techniques.
- Proposed consensus-retrieved protein residues crucial for ligand binding.
Main Results:
- Identified specific protein residues essential for MCC950 binding to NLRP3.
- Characterized key interactions stabilizing the NLRP3-ligand complex.
Conclusions:
- The computational approach offers valuable insights for rational drug design targeting NLRP3.
- This work facilitates the development of new therapeutic agents for NLRP3-associated diseases.
Related Concept Videos
02:04Protein-protein Interfaces
01:49Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...